Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials (Q35677555)

9 August 2017

title

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials (English)

1 reference

9 August 2017

0 references

2

Robert J Hancox

1 reference

9 August 2017

Sarah Haney

1

1 reference

9 August 2017

publication date

6 March 2007

1 reference

9 August 2017

1 reference

9 August 2017

volume

8

1 reference

9 August 2017

page(s)

19

1 reference

Interactions between corticosteroids and beta2-agonists

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Recovery from bronchoconstriction and bronchodilator tolerance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Muscarinic receptor signaling in the pathophysiology of asthma and COPD.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Past, present and future--beta2-adrenoceptor agonists in asthma management

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

The role of anticholinergics in acute asthma treatment: an evidence-based evaluation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the Eur

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Relation of the hypertonic saline responsiveness of the airways to exercise induced asthma symptom severity and to histamine or methacholine reactivity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Beta-adrenergic receptors and their regulation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Rapid method for measurement of bronchial responsiveness

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

The self-administration of inhaled beta agonist drugs during severe asthma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1821019

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.

27 July 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Bronchodilator tolerance: the impact of increasing bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Rapid onset of tolerance to beta-agonist bronchodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Beyond the dogma: novel beta2-adrenoceptor signalling in the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Beta2-agonist tolerance and exercise-induced bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Antagonism of beta-adrenoceptor-mediated relaxations of human bronchial smooth muscle by carbachol

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Influence of age on response to ipratropium and salbutamol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-19

Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol

21 January 2018

1 reference

12 December 2020

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

12 December 2020

A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma

1 reference

12 December 2020

Regular use of inhaled albuterol and the allergen-induced late asthmatic response

1 reference

12 December 2020

Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma

1 reference

12 December 2020

Tolerance to beta-agonists during acute bronchoconstriction

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-8-19

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference